Drtech
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Drtech makes digital X-ray imaging equipment and detectors, the hardware and software that produce medical scans used by hospitals, clinics, and veterinary practices, as well as industrial inspection systems used to examine pipelines, aircraft components, semiconductors, and batteries.
Its customers include medical facilities worldwide and industrial operators across multiple sectors. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company derives the large majority of its revenue from overseas markets, making it primarily export-driven.
Summary is AI-generated and may contain errors · figures from DART filings
Drtech in five facts
What does Drtech do?
Drtech makes digital X-ray imaging equipment and detectors, the hardware and software that produce medical scans used by hospitals, clinics, and veterinary practices, as well as industrial inspection systems used to examine pipelines, aircraft components, semiconductors, and batteries.
Where is Drtech listed and in which sector?
Drtech (Korean name: 디알텍) trades under KRX code 214680 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Drtech?
Its market capitalisation was US$44.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Drtech's latest annual revenue and operating profit?
For fiscal year 2025, Drtech reported revenue of US$87.8M, an operating loss of US$10.5M and a net loss of US$18.1M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 19.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Share cancellation decisionSep 10
- Trading suspension liftedSep 9
- Trading suspension (share consolidation/split registration)
The Korea Exchange suspended trading in Drtech Co., Ltd. common shares from 2026-08-20 until the day before the listing date of the replacement shares, due to a share consolidation.
M&A · Aug 14 - Early redemption of convertible bonds (incl. overseas CBs)
Drtech acquired US$13M in face value of its 6th-series convertible bonds before maturity on July 3, 2026, paying US$13.7M including interest, pursuant to a bondholder's early redemption request; US$13M in face value of that series remains outstanding after the acquisition.
Capital raise · Jul 3 - Material event report (convertible bonds)
Drtech disclosed convertible bonds to raise US$17.8M, about 41.6% of its market value.
Capital raise · Jun 11 - [Amended] Material event report (rights offering)Capital raise · Jan 7
- [Amended] Material event report (rights offering)Capital raise · Jan 7